Session activity on ImmunoGen, Inc.(NASDAQ:IMGN) stock is placing it on today’s most active list. After a recent spot-check, the stock has touched $5.57 which represents a change from the open of 12.59%.
Company shares have been seen trading 0.78% off of the 52 week high and 269.09% away from the 52 week low. Narrowing in, the stock is at a distance of 0.78% from the 50 day high and 96.24% off of the 50 day low.Covering sell-side analysts have recently weighed in on shares of ImmunoGen, Inc. (NASDAQ:IMGN). At the time of writing, the First Call consensus price target for the company is $5.23. The current consensus recommendation provided by covering analysts is 2.20. This recommendation lands on a scale between 1 and 5. Analysts giving shares a rating of 1 or 2 would be indicating a Buy. A rating of 4 or 5 would represent a Sell recommendation. Analysts pegging the company with a rating of 3 would be indicating a Hold recommendation.
Since the beginning of the calendar year, the stock is 140.69%. For the quarter, shares have been noted at 34.15%. Share performance for the month is currently at -9.07%. Tightening the gaze, stock performance for the last 5 trading days is 12.61%.